Paper40586387
Resveratrol: Harnessing Nature's Potential for Chronic Pain Relief.
Wu H and 10 others. Aging Dis, 2025. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Resveratrol: Harnessing Nature's Potential for Chronic Pain Relief. Papers, record 40586387. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40586387
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Resveratrol | Major topic |
| Chronic Pain | Major topic |
| Antioxidants | Major topic |
| Analgesics | Major topic |
| Humans | |
| Animals |
Source PubMed
References108
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32529694 | Resveratrol Alleviates Endoplasmic Reticulum Stress-Associated Hepatic Steatosis and Injury in Mice Challenged with Tunicamycin. | Mol Nutr Food Res | 2020 | https://conductscience.org/library/papers/32529694 | PubMed |
| 2 | 26613119 | Natural products, micronutrients, and nutraceuticals for the treatment of depression: A short review. | Nutr Neurosci | 2017 | https://conductscience.org/library/papers/26613119 | PubMed |
| 3 | 32072182 | Resveratrol suppresses bone cancer pain in rats by attenuating inflammatory responses through the AMPK/Drp1 signaling. | Acta Biochim Biophys Sin (Shanghai) | 2020 | https://conductscience.org/library/papers/32072182 | PubMed |
| 4 | 24756886 | Resveratrol reduces morphine tolerance by inhibiting microglial activation via AMPK signalling. | Eur J Pain | 2014 | https://conductscience.org/library/papers/24756886 | PubMed |
| 5 | 35269822 | The Role of Autophagy and Apoptosis in Neuropathic Pain Formation. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35269822 | PubMed |
| 6 | 33634985 | CCL4-mediated targeting of spleen tyrosine kinase (Syk) inhibitor using nanoparticles alleviates inflammatory bowel disease. | Clin Transl Med | 2021 | https://conductscience.org/library/papers/33634985 | PubMed |
| 7 | 32001342 | Resveratrol alleviates temporomandibular joint inflammatory pain by recovering disturbed gut microbiota. | Brain Behav Immun | 2020 | https://conductscience.org/library/papers/32001342 | PubMed |
| 8 | 22713680 | Resveratrol regulates N-methyl-D-aspartate receptor expression and suppresses neuroinflammation in morphine-tolerant rats. | Anesth Analg | 2012 | https://conductscience.org/library/papers/22713680 | PubMed |
| 9 | 33000199 | Resveratrol decreases high glucose‑induced apoptosis in renal tubular cells via suppressing endoplasmic reticulum stress. | Mol Med Rep | 2020 | https://conductscience.org/library/papers/33000199 | PubMed |
| 10 | 34052324 | Resveratrol for cancer therapy: Challenges and future perspectives. | Cancer Lett | 2021 | https://conductscience.org/library/papers/34052324 | PubMed |
| 11 | 27060370 | Anti-Nociceptive Effect of Resveratrol During Inflammatory Hyperalgesia via Differential Regulation of pro-Inflammatory Mediators. | Phytother Res | 2016 | https://conductscience.org/library/papers/27060370 | PubMed |
| 12 | 32392733 | The Effect of 4'-hydroxy-3,4,5-trimetoxystilbene, the Metabolite of Resveratrol Analogue DMU-212, on Growth, Cell Cycle and Apoptosis in DLD-1 and LOVO Colon Cancer Cell Lines. | Nutrients | 2020 | https://conductscience.org/library/papers/32392733 | PubMed |
| 13 | 15461555 | The therapeutic potential of Na+ and Ca2+ channel blockers in pain management. | Expert Opin Investig Drugs | 2004 | https://conductscience.org/library/papers/15461555 | PubMed |
| 14 | 10911910 | The p53 tumor suppressor gene: from molecular biology to clinical investigation. | Ann N Y Acad Sci | 2000 | https://conductscience.org/library/papers/10911910 | PubMed |
| 15 | 37564636 | Salvianolic acid B ameliorates neuroinflammation and neuronal injury via blocking NLRP3 inflammasome and promoting SIRT1 in experimental subarachnoid hemorrhage. | Front Immunol | 2023 | https://conductscience.org/library/papers/37564636 | PubMed |
| 16 | 32089065 | Activating Sirt1 by resveratrol suppresses Nav1.7 expression in DRG through miR-182 and alleviates neuropathic pain in rats. | Channels (Austin) | 2020 | https://conductscience.org/library/papers/32089065 | PubMed |
| 17 | 12939617 | Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. | Nature | 2003 | https://conductscience.org/library/papers/12939617 | PubMed |
| 18 | 10496962 | Resveratrol has antagonist activity on the aryl hydrocarbon receptor: implications for prevention of dioxin toxicity. | Mol Pharmacol | 1999 | https://conductscience.org/library/papers/10496962 | PubMed |
| 19 | 32244971 | Pioglitazone and Deoxyribonucleoside Combination Treatment Increases Mitochondrial Respiratory Capacity in m.3243A>G MELAS Cybrid Cells. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32244971 | PubMed |
| 20 | 18381589 | Resveratrol directly targets COX-2 to inhibit carcinogenesis. | Mol Carcinog | 2008 | https://conductscience.org/library/papers/18381589 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42942239 | Plant-Derived Polyphenols in Osteoarthritis: Mechanisms, Delivery Systems, and Therapeutic Synergy. | Life (Basel) | 2026 | https://conductscience.org/library/papers/42942239 | PubMed |
| 41912865 | Resveratrol therapy modulates inflammatory biomarkers and reverses mechanical allodynia in rats subjected to a temporomandibular joint arthritis model. | Inflammopharmacology | 2026 | https://conductscience.org/library/papers/41912865 | PubMed |
| 41781636 | Resveratrol alleviates neuropathic pain associated with restoration of mitochondrial fission-fusion balance in CCI mice. | Sci Rep | 2026 | https://conductscience.org/library/papers/41781636 | PubMed |
| 41588481 | Therapeutic Potential of Resveratrol in Cancer and Neurodegenerative Disorders: A Current Review. | Biofactors | 2026 | https://conductscience.org/library/papers/41588481 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40586387
GET https://conductscience.org/api/papers/v1/40586387/references?page=2